eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2018
vol. 4
 
Share:
Share:
abstract:
Review paper

Underrated enemy – from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract

Aleksandra Derra
,
Martyna Bator
,
Tomasz Menżyk
,
Michał Kukla

Clin Exp HEPATOL 2018; 4, 2: 55-71
Online publish date: 2018/05/25
View full text Get citation
 
PlumX metrics:
Nonalcoholic fatty liver disease (NAFLD) is intrahepatic ectopic lipid deposition which is present despite a lack of other causes of secondary hepatic fat accumulation. It is the most common chronic liver disorder in the welldeveloped countries. NAFLD is a multidisciplinary disease that affects various systems and organs and is inextricably linked to simple obesity, metabolic syndrome, insulin resistance and overt diabetes mellitus type 2. The positive energy balance related to obesity leads to a variety of systemic changes including modified levels of insulin, insulin- like growth factor-1, adipokines, hepatokines and cytokines. It is strongly linked to carcinogenesis and new evidence proves that NAFLD is associated with higher risk of all-cause mortality and cancer-specific mortality among cancer survivors. This article focuses on the association between NAFLD and extrahepatic gastrointestinal tract cancers, aiming to shed light on the pathomechanism of changes leading to the development of tumors.
keywords:

obesity, insulin resistance, carcinogenesis, adipokines, NAFLD

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.